Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Cancer Research UK
Cancer Research UK
Activities:
Research & Development
X
LinkedIn
Trending Articles
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Adare expands global handling & packaging capabilities
The company will have enhanced compaction, milling, bin blending and tablet compression capabilities in Philadelphia, Ohio and Milan
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Study demonstrates way to target hard-to-treat cancer mutation
The study was funded by Cancer Research UK and Wellcome
Research & Development
Aptamer and Cancer Research UK collaborate for drug discovery
The project will explore aptamers as therapeutic agents for the treatment of Chronic Myelomonocytic Leukaemia and other myeloid malignancies
Finance
Research funding round-up
Capital to support the development of new drugs and technology around the world
Research & Development
Oesophageal cancer genes leads to new drug targets
Mutations that cause oesophageal adenocarcinoma have been mapped unveiling that more than half could be targeted by drugs currently in trials for other cancer types.
Regulatory
Clinical trial launches to develop breath test for multiple cancers
Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage
Research & Development
Cancer Research UK and AstraZeneca launch functional genomics centre
The centre will be a dedicated resource for AstraZeneca and Cancer Research UK’s academics and alliance partners working at all stages of translational research
Regulatory
Patients could lose out on life-saving treatments
Limited access to novel therapies could hinder effective personalised cancer treatment in the UK, says GlobalData
Subscribe now